DelphX Announces Warrant Extension
DelphX Capital Markets (OTCQB: DPXCF) is seeking TSX Venture Exchange approval to extend the exercise period of two sets of share purchase warrants. The company aims to extend 4,825,715 warrants exercisable at $0.30 per share to August 25, 2026, and 2,825,000 warrants exercisable at $0.15 per share to August 30, 2026.
Of these warrants, 1,929,286 are held by related parties, constituting a related party transaction. The transaction qualifies for exemption from formal valuation and minority approval requirements as the warrants' fair market value is below 25% of DelphX's market capitalization.
DelphX Capital Markets (OTCQB: DPXCF) ha richiesto l'approvazione della TSX Venture Exchange per prolungare il periodo di esercizio di due serie di warrant. La società intende estendere le 4.825.715 warrant esercitabili a $0,30 per azione fino al 25 agosto 2026 e le 2.825.000 warrant esercitabili a $0,15 per azione fino al 30 agosto 2026.
Di queste, 1.929.286 sono detenute da parti correlate, configurando una transazione con parti correlate. La transazione è esente dai requisiti di valutazione formale e di approvazione delle minoranze, poiché il valore equo di mercato dei warrant è inferiore al 25% della capitalizzazione di mercato di DelphX.
DelphX Capital Markets (OTCQB: DPXCF) está solicitando la aprobación de la TSX Venture Exchange para prorrogar el periodo de ejercicio de dos series de warrants. La compañía propone extender 4.825.715 warrants ejercitables a $0,30 por acción hasta el 25 de agosto de 2026 y 2.825.000 warrants ejercitables a $0,15 por acción hasta el 30 de agosto de 2026.
De estos warrants, 1.929.286 están en manos de partes relacionadas, constituyendo una transacción con partes vinculadas. La operación queda exenta de los requisitos de valoración formal y de aprobación de minorías, dado que el valor razonable de mercado de los warrants es inferior al 25% de la capitalización bursátil de DelphX.
DelphX Capital Markets (OTCQB: DPXCF)는 두 종류의 워런트 행사 기간 연장을 위해 TSX 벤처 거래소의 승인을 신청하고 있습니다. 회사는 $0.30에 행사 가능한 4,825,715 워런트를 2026년 8월 25일까지, $0.15에 행사 가능한 2,825,000 워런트를 2026년 8월 30일까지 연장하려 합니다.
이들 중 1,929,286는 관련 당사자가 보유하고 있어 관련 당사자 거래에 해당합니다. 워런트의 공정 시장 가액이 DelphX 시가총액의 25% 미만이므로 해당 거래는 정식 평가 및 소수 주주 승인 요건의 면제를 받습니다.
DelphX Capital Markets (OTCQB: DPXCF) demande l'approbation de la TSX Venture Exchange pour prolonger la période d'exercice de deux séries de bons de souscription. La société vise à étendre 4 825 715 warrants exerçables à 0,30 $ par action jusqu'au 25 août 2026, et 2 825 000 warrants exerçables à 0,15 $ par action jusqu'au 30 août 2026.
Parmi ces warrants, 1 929 286 sont détenus par des parties liées, constituant une opération avec des parties apparentées. La transaction est exonérée des exigences d'évaluation formelle et d'approbation des minoritaires, car la juste valeur marchande des warrants est inférieure à 25 % de la capitalisation boursière de DelphX.
DelphX Capital Markets (OTCQB: DPXCF) beantragt die Zustimmung der TSX Venture Exchange zur Verlängerung der Ausübungsfrist für zwei Warrant-Serien. Das Unternehmen beabsichtigt, 4.825.715 Warrants, ausübbar zu $0,30 je Aktie, bis zum 25. August 2026 und 2.825.000 Warrants, ausübbar zu $0,15 je Aktie, bis zum 30. August 2026 zu verlängern.
Von diesen Warrants werden 1.929.286 von verbundenen Parteien gehalten, was eine Transaktion mit nahestehenden Personen darstellt. Da der beizulegende Marktwert der Warrants unter 25 % der Marktkapitalisierung von DelphX liegt, ist die Transaktion von formellen Bewertungs- und Minderheitenzustimmungsanforderungen ausgenommen.
- None.
- None.
Toronto, Ontario--(Newsfile Corp. - August 22, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products, announces that it intends to seek approval of the TSX Venture Exchange to extend the exercise period of share purchase warrants.
DelphX intends to seek approval of the TSX Venture Exchange to extend the exercise period of (i) 4,825,715 share purchase warrants, exercisable at
All other terms and conditions of the warrants will remain unchanged. The warrant extension is subject to acceptance by the TSX Venture Exchange.
A total of 1,929,286 warrants are held by parties who are considered to be "related parties" of DelphX Therefore, the amendment of Warrants constitutes a "related party transaction" as contemplated by Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions, and TSXV Policy 5.9 - Protection of Minority Security Holders in Special Transactions. However, the exemptions from formal valuation and minority approval requirements provided for can be relied upon as the fair market value of the Warrants does not exceed
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
- Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
- Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit www.delphx.com.
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/263541
FAQ
What is the purpose of DelphX's warrant extension announcement?
When will DPXCF's warrant extensions expire if approved?
How many DelphX warrants are held by related parties?
Does the DPXCF warrant extension require shareholder approval?
